BusinessProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis PatientsBy Nasdaq OMXOct 27, 2016, 11:05 AM UTC
BusinessProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis PatientsBy Nasdaq OMXOct 27, 2016, 11:05 AM UTC
BusinessImmunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2017 ResultsBy Nasdaq OMXOct 27, 2016, 11:04 AM UTC
BusinessMacroGenics Announces Date of Third Quarter 2016 Financial Results Conference CallBy Nasdaq OMXOct 26, 2016, 8:31 PM UTC
BusinessGeron Announces Conference Call to Discuss Third Quarter 2016 Financial ResultsBy Nasdaq OMXOct 26, 2016, 11:30 AM UTC
BusinessMyriad’s BRACAnalysis CDx® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Treatment with OlaparibBy Nasdaq OMXOct 26, 2016, 11:15 AM UTC
BusinessApricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in GreeceBy Nasdaq OMXOct 26, 2016, 11:00 AM UTC
BusinessTonix Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and WarrantsBy Nasdaq OMXOct 25, 2016, 9:15 PM UTC
